4//SEC Filing
Somaxon Pharmaceuticals, Inc. 4
Accession 0001209191-07-041322
CIK 0001339455operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 6:01 PM ET
Size
10.0 KB
Accession
0001209191-07-041322
Insider Transaction Report
Form 4
McGilley Meg
VP, CFO, Treasurer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2007-07-02−1,000→ 11,500 totalExercise: $1.20Exp: 2014-06-27→ Common Stock (1,000 underlying) - Sale
Common Stock
2007-07-02$12.32/sh−1,000$12,320→ 0 total - Exercise/Conversion
Common Stock
2007-07-02$1.20/sh+1,000$1,200→ 1,000 total
Holdings
- 1,166(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/12/2007.
- [F2]41 shares of common stock subject to the option are vested and exercisable as of July 5, 2007 and approximately 1,041 vest and become exercisable on the first day of each month.
- [F3]Not applicable to this transaction.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001339455
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 6:01 PM ET
- Size
- 10.0 KB